Celldex (CLDX) Announces Proposed Common Share Offering

Go back to Celldex (CLDX) Announces Proposed Common Share Offering

Celldex Therapeutics Announces Proposed Public Offering of Common Stock

June 15, 2020 4:01 PM UTC

HAMPTON, N.J., June 15, 2020 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Celldex or the Company) (Nasdaq: CLDX), today announced that it is proposing to offer and sell, subject to market conditions, shares of its common stock in an underwritten public offering. Celldex expects to grant the underwriters a 30day option to purchase up to an additional 15% of the shares of common stock offered in the public offering. All of the shares of common stock are being offered by the Company. Celldex intends to use the net proceeds from the offering to continue clinical and preclinical development of... More